Animal models of human disease Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease

Rivers, 1933, Observations on attempts to produce acute disseminated encephalomyelitis in monkeys, J. Exp. Med., 58, 39, 10.1084/jem.58.1.39 Morgan, 1946, Allergic encephalomyelitis in monkeys in response to injection of normal monkey cord, J. Bacterial., 51, 614 Kabat, 1947, The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants, J. Exp. Med., 85, 117, 10.1084/jem.85.1.117 Paterson, 1960, Transfer of allergic encephalomyelitis in rats by means of lymph node cells, J. Exp. Med., 111, 119, 10.1084/jem.111.1.119 Kies, 1965, Chemical studies on an encephalitogenic protein from guinea pig brain, Ann. N. Y. Acad. Sci., 122, 161, 10.1111/j.1749-6632.1965.tb20200.x Tuohy, 1994, Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: A review, Neurochem. Res., 19, 935, 10.1007/BF00968703 Pettinelli, 1981, Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vivo activation of lymph node cells by myelin basic protein: Requirement for Lyt-1-2+ T lymphocytes, J. Immunol., 127, 1420, 10.4049/jimmunol.127.4.1420 Swanborg, 1983, Autoimmune effector cells. V. A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis, J. Immunol., 130, 1503, 10.4049/jimmunol.130.4.1503 Ben-Nun, 1981, The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis, Eur. J. Immunol., 11, 195, 10.1002/eji.1830110307 Zamvil, 1992, The T lymphocyte in experimental allergic encephalomyelitis, Annu. Rev. Immunol., 8, 579, 10.1146/annurev.iy.08.040190.003051 Willenborg, 1979, Experimental allergic encephalomyelitis in the Lewis rat: Studies on the mechanism of recovery from disease and acquired resistance to reinduction, J. Immunol., 123, 1145, 10.4049/jimmunol.123.3.1145 Holda, 1982, Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis with a subset of T lymphocytes, Eur. J. Immunol., 12, 453, 10.1002/eji.1830120519 Welch, 1980, Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease, J. Immunol., 125, 186, 10.4049/jimmunol.125.1.186 Killen, 1982, Regulation of experimental allergic encephalomyelitis. 4. Further characterization of postrecovery suppressor cells, J. Neuroimmunol., 3, 159, 10.1016/0165-5728(82)90049-2 McDonald, 1988, Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis, J. Immunol., 140, 1132, 10.4049/jimmunol.140.4.1132 Karpus, 1991, CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta, J. Immunol., 146, 1163, 10.4049/jimmunol.146.4.1163 Martin, 1992, Immunological aspects of demyelinating diseases, Annu. Rev. Immunol., 10, 153, 10.1146/annurev.iy.10.040192.001101 Witebsky, 1928, Untersuchungen uber spezifiche antigenfunktionen von organen, Z. Immunitaetsforsch., 58, 271 McLaurin, 1993, Localization of basic proteins in human myelin, J. Neurosci. Res., 35, 618, 10.1002/jnr.490350605 Takahashi, 1985, Cloning and characterization of the myelin basic protein gene from mouse: One gene can encode both 14 kd and 18.5 kd MBPs by alternate use of exons, Cell, 42, 139, 10.1016/S0092-8674(85)80109-4 Hashim, 1977, Experimental allergic encephalomyelitis in Lewis rats: Chemical synthesis of disease-inducing determinant, Science, 196, 1219, 10.1126/science.67639 Mannie, 1985, Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: Delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes, 82, 5515 Offner, 1989, T cell determinants of myelin basic protein include a unique en cephalitogenic I-E-restricted epitope for Lewis rats, J. Exp. Med., 170, 355, 10.1084/jem.170.2.355 Jones, 1992, The synthetic 87-99 peptide of myelin basic protein is encephalitogenic in Buffalo rats, J. Neuroimnnunol., 37, 203, 10.1016/0165-5728(92)90004-5 Fritz, 1983, Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J × PI/J)F mice by myelin basic protein and its peptides: Localization of a second encephalitogenic determinant, J. Immunol., 130, 191, 10.4049/jimmunol.130.1.191 Zamvil, 1986, T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis, Nature, 324, 258, 10.1038/324258a0 Sakai, 1988, Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein, J. Neuroimmunol., 19, 21, 10.1016/0165-5728(88)90032-X Folch, 1951, Proteolipides, a new type of tissue lipoproteins, their isolation from brain, J. Biol. Chem., 191, 807, 10.1016/S0021-9258(18)55985-8 Tuohy, 1989, Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice, J. Immunol., 142, 1523, 10.4049/jimmunol.142.5.1523 Zhao, 1994, Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat, J. Immunol., 153, 901, 10.4049/jimmunol.153.2.901 Kennedy, 1990, Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides, J. Immunol., 144, 909, 10.4049/jimmunol.144.3.909 Whitham, 1991, Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL × PL)F1 mice, J. Immunol., 147, 3803, 10.4049/jimmunol.147.11.3803 Linington, 1993, T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system, Eur. J. Immunol., 23, 1364, 10.1002/eji.1830230627 Kojima, 1994, Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia, J. Exp. Med., 180, 817, 10.1084/jem.180.3.817 Ota, 1990, T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis, Nature, 346, 183, 10.1038/346183a0 Martin, 1991, A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis, J. Exp. Med., 173, 19, 10.1084/jem.173.1.19 Trotter, 1991, Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides, J. Neuroimmunol., 33, 55, 10.1016/0165-5728(91)90034-5 Pelfrey, 1993, Identification of a novel T cell epitope of human proteolipid protein (residues 40–60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients, J. Neuroimmunol., 46, 33, 10.1016/0165-5728(93)90231-M Chou, 1992, Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis, J. Neuroimmunol., 38, 105, 10.1016/0165-5728(92)90095-3 Burns, 1989, J. Exp. Med., 169, 27, 10.1084/jem.169.1.27 Chluba, 1989, T cell receptor β chain usage in myelin basic protein specific rat T lymphocytes, Eur. J. Immunol., 19, 279, 10.1002/eji.1830190210 Sun, 1992, Characterization of rat encephalitogenic T cells bearing non-Vβ8 receptors, Eur. J. Immunol., 22, 591, 10.1002/eji.1830220244 Sakai, 1988, Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein, 85, 8608 Greer, 1992, Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178–191) for SJL mice, J. Immunol., 149, 783, 10.4049/jimmunol.149.3.783 Kuchroo, 1992, Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: Fine specificity and T cell receptor Vβ usage, J. Immunol., 148, 3776, 10.4049/jimmunol.148.12.3776 Oksenberg, 1993, Selection for T cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis, Nature, 362, 68, 10.1038/362068a0 Allegretta, 1994, Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis, J. Clin. Invest., 94, 105, 10.1172/JCI117295 Mustafa, 1991, T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats, J. Neuroimmunol., 31, 165, 10.1016/0165-5728(91)90022-Y Powell, 1990, Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity, Int. Immunol., 2, 539, 10.1093/intimm/2.6.539 McCarron, 1986, Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells, J. Immunol., 137, 3428, 10.4049/jimmunol.137.11.3428 Cannella, 1991, Adhesion-related molecules in the central nervous system: Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis, Lab. Invest., 65, 23 Baron, 1993, Surface expression of alpha-4 integrin by CD4 T cells is required for their entry into brain parenchyma, J. Exp. Med., 177, 57, 10.1084/jem.177.1.57 Paterson, 1987, Role of the clotting system in the pathogenesis of neuroimmunologic disease, 46, 91 Claudio, 1990, Mechanisms of edema formation in experimental autoimmune encephalomyelitis: The contribution of inflammatory cells, Am. J. Pathol., 137, 1033 Swanborg, 1988, Experimental allergic encephalomyelitis, Methods Enzymol., 162, 413, 10.1016/0076-6879(88)62095-7 Polman, 1988, Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat, J. Neuroimmunol., 17, 209, 10.1016/0165-5728(88)90069-0 Pender, 1990, The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin. A, Acta Neuropathol., 80, 172, 10.1007/BF00308921 Feurer, 1985, Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat, J. Neuroimmunol., 10, 159, 10.1016/0165-5728(85)90006-2 Lublin, 1981, Delayed, relapsing experimental allergic encephalomyelitis in mice, J. Immunol., 126, 819, 10.4049/jimmunol.126.3.819 Fritz, 1983, Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein, J. Immunol., 130, 1024, 10.4049/jimmunol.130.3.1024 Mokhtarian, 1984, Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice, Nature, 309, 356, 10.1038/309356a0 Cross, 1987, Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection, Lab. Invest., 57, 499 Tuohy, 1988, Myelin proteolipid protein-induced experimental allergic encephalomyelitis: Variations of disease expression in different strains of mice, J. Immunol., 140, 1868, 10.4049/jimmunol.140.6.1868 Van der Veen, 1989, The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein, J. Neuroimmunol., 21, 183, 10.1016/0165-5728(89)90174-4 Ben-Nun, 1981, Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line, Eur. J. Immunol., 11, 949, 10.1002/eji.1830111119 Howell, 1989, Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides, Science, 246, 668, 10.1126/science.2814489 Vandenbark, 1989, Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis, Nature, 341, 541, 10.1038/341541a0 Desquenne-Clark, 1991, T cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis, 88, 7219 Tsuchida, 1993, Preferential distribution of Vβ8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis, Eur. J. Immunol., 23, 2399, 10.1002/eji.1830231004 Bell, 1993, Diverse T cell receptor Vβ gene usage in the central nervous system in experimental allergic encephalomyelitis, J. Immunol., 150, 4085, 10.4049/jimmunol.150.9.4085 Karin, 1993, Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis, J. Immunol., 150, 4116, 10.4049/jimmunol.150.9.4116 Sun, 1994, Characterization of brain-isolated rat encephalitogenic T cell lines, Eur. J. Immunol., 24, 1359, 10.1002/eji.1830240618 Heber-Katz, 1989, The V-region disease hypothesis: Evidence from autoimmune encephalomyelitis, Immunol. Today, 10, 164, 10.1016/0167-5699(89)90174-6 Gold, 1991, Analysis of T cell receptor β chains in Lewis rats with experimental allergic encephalomyelitis: Conserved complementarity determining region 3, J. Exp. Med., 174, 1467, 10.1084/jem.174.6.1467 Wilson, 1993, The V-region disease hypothesis: New evidence suggests it is probably wrong, Immunol. Today, 14, 376, 10.1016/0167-5699(93)90136-9 Bourdette, 1994, Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides, J. Immunol., 152, 2510, 10.4049/jimmunol.152.5.2510 Lehmann, 1992, Spreading of T cell autoimmunity to cryptic determinants of an autoantigen, Nature, 358, 155, 10.1038/358155a0 Swierkosz, 1975, Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis, J. Immunol., 115, 631, 10.4049/jimmunol.115.3.631 Adda, 1977, Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis, Eur. J. Immunol., 7, 620, 10.1002/eji.1830070908 Karpus, 1992, CD4+ suppressor cells of autoimmune encephalomyelitis respond to TCR-associated determinants on effector cells by IL-4 secretion, Eur. J. Immunol., 22, 1757, 10.1002/eji.1830220714 Chen, 1994, Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis, Science, 265, 237, 10.1126/science.7520605 Karpus, 1989, CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis, J. Immunol., 143, 3492, 10.4049/jimmunol.143.11.3492 Stevens, 1994, Transforming growth factor-β1 inhibits tumor necrosis factor-α/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis, J. Neuroimmunol., 51, 77, 10.1016/0165-5728(94)90131-7 Schluesener, 1989, Transforming growth factors β1 and β2: Cytokines with identical immunosuppressive effects and potential role in the regulation of autoimmune T cell function, J. Neuroimmunol., 24, 249, 10.1016/0165-5728(89)90123-9 Racke, 1991, Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1, J. Immunol., 146, 3012, 10.4049/jimmunol.146.9.3012 Kuruvilla, 1991, Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice, 88, 2918 Johns, 1991, Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1, J. Immunol., 147, 1792, 10.4049/jimmunol.147.6.1792 Miller, 1992, Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering, 89, 421 Whitacre, 1991, Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy, J. Immunol., 147, 2155, 10.4049/jimmunol.147.7.2155 Racke, 1994, Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease, J. Exp. Med., 180, 1961, 10.1084/jem.180.5.1961 Sun, 1988, Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions, Nature, 332, 843, 10.1038/332843a0 Antel, 1986, Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis, J. Immunol., 137, 3436, 10.4049/jimmunol.137.11.3436 Reinherz, 1980, Loss of suppressor T cells in active multiple sclerosis, N. Engl. J. Med., 303, 125, 10.1056/NEJM198007173030303 Mokhtarian, 1994, Defective production of anti-inflammatory cytokine TGF-β by T cell lines of patients with active multiple sclerosis, J. Immunol., 152, 6003, 10.4049/jimmunol.152.12.6003 Voskuhl, 1993, T helper 1 (TH1) functional phenotype of human myelin basic protein-specific T lymphocytes, Autoimmunity, 15, 137, 10.3109/08916939309043888 Pender, 1992, Apoptosis of αβ T lymphocytes in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance, J. Autoimmunity, 5, 401, 10.1016/0896-8411(92)90001-7 MacPhee, 1989, Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids, J. Exp. Med., 169, 431, 10.1084/jem.169.2.431 Weiner, 1993, Double-blind pilot study of oral tolerization with myelin antigens in multiple sclerosis, Science, 259, 1321, 10.1126/science.7680493 1993, Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial, Neurology, 43, 655, 10.1212/WNL.43.4.655